83_FR_21391 83 FR 21301 - National Institute on Drug Abuse; Notice of Closed Meeting

83 FR 21301 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 90 (May 9, 2018)

Page Range21301-21301
FR Document2018-09901

Federal Register, Volume 83 Issue 90 (Wednesday, May 9, 2018) 
[Federal Register Volume 83, Number 90 (Wednesday, May 9, 2018)]
[Notices]
[Page 21301]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-09901]



[[Page 21301]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Rodent Testing to Identify Pharmacotherapies for 
Substance Dependence (8936).
    Date: May 24, 2018.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: May 4, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-09901 Filed 5-8-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 90 / Wednesday, May 9, 2018 / Notices 21301 DEPARTMENT OF HEALTH AND as amended. The grant applications and Health,6701 Rockledge Drive, Room 3139, HUMAN SERVICES the discussions could disclose MSC 7770,Bethesda, MD 20892,(301) 435– confidential trade secrets or commercial 1712,ryansj@csr.nih.gov. National Institutes of Health property such as patentable material, Name of Committee: Center for Scientific and personal information concerning Review Special Emphasis Panel;Behavioral National Institute on Drug Abuse; Genetics and Epidemiology: Collaborative individuals associated with the grant Applications. Notice of Closed Meeting applications, the disclosure of which Date: May 30, 2018. Pursuant to section 10(d) of the would constitute a clearly unwarranted Time: 8:30 a.m. to 5:00 p.m. Federal Advisory Committee Act, as invasion of personal privacy. Agenda: To review and evaluate grant amended, notice is hereby given of the Name of Committee: Center for Scientific applications. following meeting. Review Special Emphasis Panel;RFA Panel: Place: InterContinental Chicago Hotel,505 African Health Professional Education North Michigan Avenue,Chicago, IL 60611. The meeting will be closed to the Partnership Initiative. Contact Person: Suzanne Ryan, public in accordance with the Ph.D.,Scientific Review Officer,Center for provisions set forth in sections Date: May 22, 2018. Time: 10:00 a.m. to 5:00 p.m. Scientific Review,National Institutes of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: To review and evaluate grant Health,6701 Rockledge Drive, Room 3139, as amended. The contract proposals and applications. MSC 7770,Bethesda, MD 20892,(301) 435– the discussions could disclose Place: National Institutes of Health,6701 1712,ryansj@csr.nih.gov. confidential trade secrets or commercial Rockledge Drive,Bethesda, MD Name of Committee: Surgical Sciences, property such as patentable material, 20892,(Virtual Meeting). Biomedical Imaging and Bioengineering and personal information concerning Contact Person: Shalanda A Bynum, Ph.D., Integrated Review Group;Biomedical Imaging MPH,Scientific Review Officer,Center for Technology B Study Section. individuals associated with the contract Scientific Review,National Institutes of Date: May 31–June 1, 2018. proposals, the disclosure of which Time: 8:00 a.m. to 6:00 p.m. Health,6701 Rockledge Drive, Room would constitute a clearly unwarranted Agenda: To review and evaluate grant 3206,Bethesda, MD 20892,301–755– invasion of personal privacy. 4355,bynumsa@csr.nih.gov. applications. Name of Committee: National Institute on Place: Hilton Washington/Rockville,1750 Name of Committee: Center for Scientific Drug Abuse Special Emphasis Panel; Rodent Rockville Pike,Rockville, MD 20852. Review Special Emphasis Panel;RFA 17–245: Testing to Identify Pharmacotherapies for Contact Person: Mehrdad Mohseni, Mammalian Models for Translational Substance Dependence (8936). MD,Scientific Review Officer,Center for Research. Date: May 24, 2018. Scientific Review,National Institutes of Date: May 22, 2018. Time: 10:00 a.m. to 12:00 p.m. Health,6701 Rockledge Drive, Room 5211, Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract MSC 7854,Bethesda, MD 20892,301–435– Agenda: To review and evaluate grant proposals. 0484,mohsenim@csr.nih.gov. applications. Place: National Institutes of Health, Place: National Institutes of Health,6701 Name of Committee: Surgical Sciences, Neuroscience Center, 6001 Executive Rockledge Drive,Bethesda, MD 20892(Virtual Biomedical Imaging and Bioengineering Boulevard, Rockville, MD 20852 (Telephone Meeting). Integrated ReviewGroup;Medical Imaging Conference Call). Contact Person: Careen K Tang-Toth, Study Section. Contact Person: Lyle Furr, Scientific Ph.D.,Scientific Review Officer,Center for Date: May 31–June 1, 2018. Review Officer, Office of Extramural Affairs, Scientific Review,National Institutes of Time: 8:00 a.m. to 6:00 p.m. National Institute on Drug Abuse, NIH, Health,6701 Rockledge Drive, Room 6214, Agenda: To review and evaluate grant DHHS, Room 4227, MSC 9550, 6001 MSC 7804,Bethesda, MD 20892,(301) 435– applications. Executive Boulevard, Bethesda, MD 20892– 3504,tothct@csr.nih.gov. Place: Hyatt Regency Bethesda,One 9550, (301) 827–5702, lf33c.nih.gov. Bethesda Metro Center,7400 Wisconsin Name of Committee: Center for Scientific (Catalogue of Federal Domestic Assistance Avenue,Bethesda, MD 20814. Review Special Emphasis Panel;RFA–CA– Program No.: 93.279, Drug Abuse and Contact Person: Xiang-Ning Li, MD, 17–038: Accelerating Colorectal Cancer Addiction Research Programs, National Ph.D.,Scientific Review Officer,Center for Screening and Follow-up: TheMoonshot Institutes of Health, HHS) Scientific Review,National Institutes of Initiative. Health,6701 Rockledge Drive, Room 5112, Dated: May 4, 2018. Date: May 30, 2018. MSC 7854,Bethesda, MD 20892,301–435– Time: 8:00 a.m. to 6:30 p.m. Natasha M. Copeland, 1744,lixiang@csr.nih.gov. Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory applications. Name of Committee: Vascular and Committee Policy. Place: Embassy Suite by Hilton Hematology Integrated Review Group; [FR Doc. 2018–09901 Filed 5–8–18; 8:45 am] Washington DC,Chevy Chase Pavilion,4300 Molecular and Cellular Hematology Study BILLING CODE 4140–01–P Military Road NW,Washington, DC 20015. Section. Contact Person: Shalanda A Bynum, Ph.D., Date: June 4–5, 2018. MPH,Scientific Review Officer,Center for Time: 8:00 a.m. to 5:00 p.m. Scientific Review,National Institutes of Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND applications. HUMAN SERVICES Health,6701 Rockledge Drive, Room 3206,Bethesda, MD 20892,301–755– Place: Crowne Plaza Houston River Oaks, 4355,bynumsa@csr.nih.gov. 2712 Southwest Freeway, Houston, TX National Institutes of Health 77098. Name of Committee: Population Sciences and Epidemiology Integrated Review Contact Person: Luis Espinoza, Ph.D., Center for Scientific Review; Notice of Scientific Review Officer, Center for Group;Behavioral Genetics and Epidemiology Closed Meetings Study Section. Scientific Review, National Institutes of Date: May 30, 2018. Health, 6701 Rockledge Drive, Room 6183, Pursuant to section 10(d) of the MSC 7804, Bethesda, MD 20892, 301–495– amozie on DSK3GDR082PROD with NOTICES Federal Advisory Committee Act, as Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant 1213, espinozala@mail.nih.gov. amended, notice is hereby given of the applications. Name of Committee: Center for Scientific following meetings. Place: InterContinental Chicago Hotel,505 Review Special Emphasis Panel; PAR–18– The meetings will be closed to the North Michigan Avenue,Chicago, IL 60611. 681: Fundamental Mechanism of Affective public in accordance with the Contact Person: Suzanne Ryan, and Decisional Process in Cancer Control. provisions set forth in sections Ph.D.,Scientific Review Officer,Center for Date: June 5, 2018. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review,National Institutes of Time: 10:30 a.m. to 2:00 p.m. VerDate Sep<11>2014 17:39 May 08, 2018 Jkt 244001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\09MYN1.SGM 09MYN1


Document Created: 2018-05-09 03:17:28
Document Modified: 2018-05-09 03:17:28
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 24, 2018.
FR Citation83 FR 21301 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR